OBJECTIVE To discuss the relation between the fungal infection and differential leukocyte count,fever and death rate,for progressing clinical diagnosis and therapy in fungal infection. METHODS The patients were divided into septicemia groups,lung infection groups,biliary tract infection groups,nerve center and local urinary tract groups,intestinal tract groups,and normal control groups.And the differential leukocyte count,and fever and death rate were analyzed. RESULTS The Aspergillus,Candida and Cryptococcus were occupied 90.8% for deep fungal infection,and the Aspergillus caused patients death rate to 88.9%;fungal infection for septicemia,lungs,biliary tract caused patients fever rate was to 100%,but urinary tract,intestinal tract and nerve center behaved variously.For lungs the Aspergillus and Penicillium caused differential leukocyte WBC count had high than the control signficant difference,P0.05. CONCLUSIONS The deep fungal infection caused higher patients fever rate,and the Aspergillus and Penicillium caused higher differential leukocyte count,but deep and local yeast was not.Currently the Aspergillus,Candida and Cryptococcus are three main opportunistic infected fungi.

Cyclodipeptide (CDP) composed of two amino acids is the simplest cyclic peptide. These two amino acids form a typical diketopiperazine (DKP) ring by linking each other with peptide bonds. This characteristic stable ring skeleton is the foundation of CDP to display extensive and excellent bioactivities, which is beneficial for CDPs' pharmaceutical research and development. The natural CDP products are well isolated from actinomycetes. These bacteria can synthesize DKP backbones with nonribosomal peptide synthetase (NRPS) or cyclodipeptide synthase (CDPS). Moreover, actinomycetes could produce a variety of CDPs through different enzymatic modification. The presence of these abundant and diversified catalysis indicates that actinomycetes are promising microbial resource for exploring CDPs. This review summarized the pathways for DKP backbones biosynthesis and their post-modification mechanism in actinomycetes. The aim of this review was to accelerate the genome mining of CDPs and their isolation, purification and structure identification, and to facilitate revealing the biosynthesis mechanism of novel CDPs as well as their synthetic biology design.
Actinobacteria/metabolism* ; Actinomyces/metabolism* ; Biological Products/metabolism* ; Bacteria/metabolism* ; Diketopiperazines/metabolism* ; Amino Acids